Neuro-Oncology Advances · 2022 · 19 citations · 36 references
These data suggest that LITT+SRT is superior to LITT or repeat SRT alone for treatment of biopsy-proven brain metastasis recurrence after SRT failure. Prospective trials are warranted to validate the efficacy of using combination LITT+SRT for treatment of recurrent brain metastases.
36
Eric L. Chang, Jeffrey S. Wefel, Kenneth R. Hess et al. · The Lancet Oncology · 2009 · 2.4K citations
Edward Shaw, Charles Scott, Luís Souhami et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 1.6K citations
Orrin Devinsky, S. Pacia · PubMed · 1993 · 1.2K citations